2018 Diagnostic & Therapeutic Advances Across the Global Biotech Landscape - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 19, 2018--The “Recent Diagnostic and Therapeutic Advances Across the Global Biotech Landscape” report has been added to ResearchAndMarkets.com’s offering.
This edition of the Genetic Technology TOE depicts new life sciences trends across diagnostics and therapeutics. Different diagnostic approaches including liquid biopsy tests for autism and related disorders are illustrated along with a number of therapeutic innovations for neurodegenerative diseases. The recent advances in personalized medicine initiatives in oncology and the consequent progress across the immuno-oncology pipeline are also included. The corresponding clinical trials scenario is also depicted.
The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.
Key Topics Covered
1. Diagnostic & Therapeutic Advances in BiotechLiquid Biopsy Test for Autism Novel Therapeutics for Neurodegenerative Diseases Advancing Personalized Medicine Initiatives in Oncology Advances in Immuno-oncology Pipeline
2. Clinical Trial Analysis and Industry InteractionsClinical Trial Analysis Key Contacts
For more information about this report visit https://www.researchandmarkets.com/research/h3cwsj/2018_diagnostic?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180919005674/en/
Laura Wood, Senior Manager
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY GENETICS
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/19/2018 01:38 PM/DISC: 09/19/2018 01:38 PM